Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Courtney D. Dinardo

A Phase II Study of Omacetaxine Mepesuccinate for Patients With Higher-Risk Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia After Failure of Hypomethylating Agents

American Journal of Hematology

Hematology

2018

English

Related publications

Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis

Clinical Lymphoma, Myeloma and Leukemia

English

Systematic Literature Review of Treatment Options and Clinical Outcomes for Patients With Higher Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Clinical Lymphoma, Myeloma and Leukemia

English

Transplantation for Myelodysplastic Syndrome in the Era of Hypomethylating Agents

Current Opinion in Hematology

Hematology

2012

English

A Phase II Study of AZD2171 (Cediranib) in the Treatment of Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Leukemia and Lymphoma

English

Superior Outcome With Hypomethylating Therapy in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome and Chromosome 5 and 7 Abnormalities

English

Combination Therapies of Hypomethylating Agents for Elderly Patients With Acute Myeloid Leukemia

Acta Haematologica Polonica

Oncology

Hematology

2018

English

Heterogeneous Patterns of CEBP Mutation Status in the Progression of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia to Acute Myelogenous Leukemia

Clinical Cancer Research

Cancer Research

Oncology

2005

English

Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia, and Acute Myeloid Leukemia Associated With Complete or Partial Monosomy 7

English

Hypomethylating Agents in Combination With Histone Deacetylase Inhibitors in Higher Risk Myelodysplastic Syndromes: Is There a Light at the End of the Tunnel?

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Courtney D. Dinardo

A Phase II Study of Omacetaxine Mepesuccinate for Patients With Higher-Risk Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia After Failure of Hypomethylating Agents

Related publications

Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis

Systematic Literature Review of Treatment Options and Clinical Outcomes for Patients With Higher Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Transplantation for Myelodysplastic Syndrome in the Era of Hypomethylating Agents

A Phase II Study of AZD2171 (Cediranib) in the Treatment of Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Superior Outcome With Hypomethylating Therapy in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome and Chromosome 5 and 7 Abnormalities

Combination Therapies of Hypomethylating Agents for Elderly Patients With Acute Myeloid Leukemia

Heterogeneous Patterns of CEBP Mutation Status in the Progression of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia to Acute Myelogenous Leukemia

Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia, and Acute Myeloid Leukemia Associated With Complete or Partial Monosomy 7

Hypomethylating Agents in Combination With Histone Deacetylase Inhibitors in Higher Risk Myelodysplastic Syndromes: Is There a Light at the End of the Tunnel?